Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Lilly's new 5-HT1D agonists claimed for CNS and bladder disorders

Jan. 4, 1999

OPC-31260: potential utility in cirrhosis patients with impaired water handling

Dec. 30, 1998

Tobishi's pollen extract improves bladder dysfunction, nonbacterial prostatitis in rats

Dec. 21, 1998

FDA clears first and only once-daily treatment for overactive bladder

Dec. 21, 1998

New agents for micturition disorders discovered at Kyowa Hakko

Dec. 16, 1998

Vanguard drops hyperphosphatemia Rx from development pipeline

Dec. 16, 1998

Fujisawa describes potential new agent for treating BPH

Dec. 8, 1998

Pharmacokinetic studies support chronic dosing of FK-143

Dec. 3, 1998

Health Canada approves first new incontinence medication in over a decade

Dec. 3, 1998

Tamsulosin improves signs and symptoms of BPH in phase III study

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...